Screener
Aspen Aerogels ASPN Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aspen Aerogels in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Aspen Aerogels’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-214672
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Accrued expenses | 5,015 | (19,814) |
| Deferred revenue | 35,319 | 446 |
| Operating lease and other liabilities | (1,034) | (1,062) |
| Net cash provided by operating activities | 34,145 | 5,632 |
| Cash flows from investing activities: | ||
| Capital expenditures | (1,367) | (12,998) |
| Net cash used in investing activities | (1,367) | (12,998) |
| Cash flows from financing activities: |
Item 1. Financial Statements.
FAQ
- What is Aspen Aerogels's operating cash flow?
- Aspen Aerogels (ASPN) reported operating cash flow of $34.15M in Q1 2026.
- How has Aspen Aerogels's operating cash flow changed year-over-year?
- Aspen Aerogels's operating cash flow increased by 506.3% year-over-year, from $5.63M to $34.15M.
- What is the long-term trend for Aspen Aerogels's operating cash flow?
- Over 3 years (2021 to 2024), Aspen Aerogels's operating cash flow has grown at a 31.6% compound annual growth rate (CAGR), from -$19.97M to $45.55M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Aspen Aerogels's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude